Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Exact Sciences | 15 | 0 | 2 | 0 | €42.39 | €77.33 | 82.424% |
| GSK plc ADR | 6 | 0 | 2 | 0 | €36.60 | €49.33 | 34.773% |
| Humana Inc. | 24 | 0 | 2 | 0 | €366.80 | €395.69 | 7.875% |
| Sartorius AG VZO | 5 | 0 | 2 | 0 | €243.80 | - | - |
| Amgen Inc. | 25 | 0 | 2 | 0 | €308.45 | €304.65 | -1.233% |
| Alnylam Pharmace. | 44 | 0 | 2 | 0 | €219.00 | €253.95 | 15.961% |
| Taro Pharmaceutical Industries Ltd | 11 | 0 | 2 | 0 | €40.00 | - | - |
| Pfizer Inc. | 29 | 4 | 2 | 0 | €28.35 | €41.29 | 45.661% |
| Verastem Inc. | 12 | 0 | 2 | 0 | €2.74 | €17.56 | 540.730% |
| CONMED Corp. | 11 | 1 | 1 | 0 | €65.50 | €100.05 | 52.740% |
| Iovance Biotherapeutics Inc. | 22 | 2 | 1 | 0 | €8.52 | €26.25 | 207.911% |
| Novartis AG ADR | 3 | 0 | 1 | 0 | €102.00 | €112.40 | 10.194% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €124.45 | €182.96 | 47.015% |
| Puma Biotechnology Inc. | 1 | 0 | 1 | 0 | €3.52 | - | - |
| Brainstorm Cell | 2 | 0 | 1 | 0 | €0.32 | €1.84 | 478.583% |
| Teleflex Inc. | 10 | 0 | 1 | 0 | €204.00 | €244.75 | 19.977% |
| Henry Schein Inc. | 14 | 1 | 1 | 0 | €64.84 | €80.03 | 23.419% |
| Sangamo Therapeutics Inc. | 13 | 16 | 1 | 4 | €0.79 | €4.10 | 417.030% |
| Celldex Therapeutics | 16 | 1 | 1 | 0 | €41.20 | €61.99 | 50.457% |
| Lexicon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.20 | €9.17 | 317.197% |
| AnaptysBio Inc | 9 | 1 | 1 | 0 | €34.60 | €46.24 | 33.642% |
| X4 Pharmaceuticals, Inc. | 7 | 0 | 1 | 0 | €0.79 | €4.61 | 481.211% |
| Incyte Corp. | 13 | 2 | 1 | 1 | €63.20 | €77.67 | 22.898% |
| Healthstream Inc. | 4 | 0 | 1 | 0 | €26.60 | €29.29 | 10.123% |
| Novo Nordisk A/S ADR | 20 | 1 | 1 | 0 | €117.00 | €144.02 | 23.093% |